SCHEMBL25043136

SCHEMBL25043136

Cc1cccc(-c2c[nH]c3ccccc23)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ASH1L Q9NR48 1/20 0.59
▸ IMPDH2 P12268 2/20 0.53
▸ NR4A2 P43354 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ TDO2 P48775 7/20 0.53
▸ PRKCB P05771 1/20 0.51
▸ CDK4 P11802 1/20 0.51
▸ CCND1 P24385 1/20 0.51
▸ ATM Q13315 2/20 0.48
▸ PTPN1 P18031 1/20 0.48
▸ MAOA P21397 1/20 0.48
▸ MAOB P27338 1/20 0.48
▸ PDGFRB P09619 1/20 0.48
▸ PDGFRA P16234 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30620453 0.86 IMPDH2 (0.56) ASH1LIMPDH2NR4A2MAPK1HSD17B10
SCHEMBL15949729 0.85 ASH1L (0.55) ASH1LIMPDH2NR4A2MAPK1HSD17B10
SCHEMBL18418496 0.80 NR4A2 (0.68) IMPDH2NR4A2MAPK1HSD17B10TDO2
SCHEMBL31517811 0.80 NR4A2 (0.68) IMPDH2NR4A2MAPK1HSD17B10TDO2
SCHEMBL26703619 0.80 DYRK1A (0.66) IMPDH2MAPK1HSD17B10TDO2
SCHEMBL6586643 0.79 ASH1L (0.59) ASH1LIMPDH2NR4A2MAPK1HSD17B10
SCHEMBL23259083 0.79 ASH1L (0.59) ASH1LCDK4CCND1ATM
SCHEMBL29824426 0.79 ASH1L (0.63) ASH1LIMPDH2NR4A2MAPK1HSD17B10
SCHEMBL23649189 0.79 ASH1L (0.63) ASH1LIMPDH2NR4A2MAPK1HSD17B10
SCHEMBL30695578 0.79 ASH1L (0.59) ASH1LIMPDH2NR4A2MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4134364-A2 BROMODOMAIN INHIBITORS Celgene Quanticel Research, Inc. (US) 2023-02-15 — — EP disclosed
Send feedback